BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Prostate
,
Metabolism of nitric oxide
,
Ciprofibrate
,
rs2300478
,
FABP1
,
Obesity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
nonalcoholic steatohepatitis
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
FOS
NOG
FOSB
CYR61
TNFRSF17
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
PILON_KLF1_TARGETS_DN
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
cytosol
heterocyclic compound binding
PUJANA_BRCA1_PCC_NETWORK
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Livers from nonalcoholic steatohepatitis model mice treated with metformin
Livers with STAM-induced steatosis, steatohepatitis, fibrosis, and hepatocellular carcinoma
Liver tissues from vehicle or I-BET-151-treated STAM mice models of nonalcoholic steatohepatitis
Livers after NASH-inducing diet treated with astaxanthine or vitamin E
Diseased liver tissue miRNA expression profiles
Explore Curated Studies Results
Literature
Most Relevant Literature
Markers in nonalcoholic steatohepatitis.
Dietary treatment of nonalcoholic steatohepatitis.
Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection be…
A myriad of pathways to NASH.
Evolving aspects of liver transplantation for nonalcoholic steatohepatitis.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Predicting Outcomes in Nonalcoholic Steatohepatitis With Advanced Fibrosis
Using Hydroxychloroquine to Treat Nonalcoholic Steatohepatitis
Predictable MR Index for Nonalcoholic Steatohepatitis (NASH)
Treatment of Nonalcoholic Steatohepatitis With Pioglitazone
JKB-121 for the Treatment of Nonalcoholic Steatohepatitis
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ